PDF

Int J Biol Sci 2007; 3(1):57-63. doi:10.7150/ijbs.3.57 This issue Cite

Short Research Communication

Prion-derived copper-binding peptide fragments catalyze the generation of superoxide anion in the presence of aromatic monoamines

Tomonori Kawano

Graduate School of Environmental Engineering, The University of Kitakyushu, Kitakyushu 808-0135, Japan

Abstract

Objectives: Studies have proposed two opposing roles for copper-bound forms of prion protein (PrP) as an anti-oxidant supporting the neuronal functions and as a pro-oxidant leading to neurodegenerative process involving the generation of reactive oxygen species. The aim of this study is to test the hypothesis in which putative copper-binding peptides derived from PrP function as possible catalysts for monoamine-dependent conversion of hydrogen peroxide to superoxide in vitro.

Materials and methods: Four peptides corresponding to the copper (II)-binding motifs in PrP were synthesized and used for analysis of peptide-catalyzed generation of superoxide in the presence of Cu (II) and other factors naturally present in the neuronal tissues.

Results: Among the Cu-binding peptides tested, the amino acid sequence corresponding to the Cu-binding site in the helical region was shown to be the most active for superoxide generation in the presence of Cu(II), hydrogen peroxide and aromatic monoamines, known precursors or intermediates of neurotransmitters. Among monoamines tested, three compounds namely phenylethylamine, tyramine and benzylamine were shown to be good substrates for superoxide-generating reactions by the Cu-bound helical peptide.

Conclusions: Possible roles for these reactions in development of prion disease were suggested.

Keywords: aromatic monoamine, copper, prion, redox, superoxide

1. Introduction

Prion protein (PrP) from the brains of animals with transmissible spongiform encephalopathies (TSE) is present as partially protease-resistant form while that in uninfected brains presents as fully sensitive form [1]. In general, the former represents the infectious scrapie isoform of PrP (PrP^Sc) and the latter represents the intrinsic cellular PrP (PrP^C). Such deposition of abnormal protein fibrils is a prominent pathological feature of many different “protein conformational” diseases, including not only “prion” dementias but also some important neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and motor neuron disease [2]. In the cases of β-amyloid which accumulates in the brain in Alzheimer's disease and of α-synuclein accumulating in Lewy bodies in Parkinson's disease, there are good evidences that the toxic mechanism involves the production of reactive oxygen species (ROS) such as H₂O₂ and hydroxyl radicals (HO^·), supporting the view that one of the fundamental molecular mechanisms underlying the pathogenesis of cell death in neurodegenerative diseases could be the direct production of ROS during formation of the abnormal protein aggregates [2,3].

As generalized in Fig. 1, PrPs from mammals have six to seven putative Cu-binding sites consisted of 4 distinct sequences. Opazo et al. [4] have propounded the importance of metals in neurobiology and proposed two opposing roles for copper-bound PrP as an anti-oxidant required for the neuronal functions and as a pro-oxidant leading to neurodegenerative process. To date, anti-oxidative roles of PrP^C are well recognized. It has been shown that E. coli cells expressing PrP sequence (octapeptide repeats region) acquired the resistance to Cu and Cu-dependent oxidative damages, indicating that PrP^C possibly contributes to protection of cells from free Cu-catalyzed generation of ROS such as HO^· [5]. According to Wong et al. [6], Cu-bound PrP^C shows a superoxide dismutase (SOD)-like activity in vitro, and its expression likely contributes to the cellular response to oxidative damages to the cells. Sauer et al. [7] have shown in tumor spheroids that an increase in ROS stimulates the production of PrP^C and other ROS scavenging enzymes such as Cu, Zn-SOD and catalase, while ROS-lowering treatments effectively down-regulate the expression of PrP^C, implying that PrP^C expression in tumor spheroids is regulated by the internal redox state to meet the requirement to protect the cells from ROS. Interestingly, a drastic depress in SOD-like activity has been shown in the affinity-purified total PrP preparation isolated from scrapie-infected mouse brains suggesting that prion disease results in denature of PrP thus no longer active in ROS removal [6].

However, contrary to above reports, there are views questioning the proposed SOD-like activity of PrPs. Jones et al. [8] have reported that recombinant PrP exhibits no detectable dismutase activity above baseline levels measured for copper (II) ions.

It is generally accepted that, like amyloid-β peptide, prion induces apoptotic cell death in neuronal tissues [9]. A PrP amino acid sequence 106-126 covering a putative Cu-binding site, likely forms the region causing neuronal apoptosis since a synthetic Cu-bound peptide corresponding to PrP 106-126 is highly fibrillogenic and highly toxic to neuronal cells as if behaving as a PrP^Sc mimic [9,10].

 Figure 1 

Copper-binding motifs in PrP protein. (A) Putative copper-binding domains present in PrP protein and variations in amino acid sequences required for binding to copper. Histidine residues possibly involved in anchoring of copper are marked with asterisks. (B) Four peptide sequences corresponding to copper-binding motifs in PrP. (1) The most characterized Cu-binding sequence repeated 4 times in human, mouse and ovine, 6 times in bovine was used. (2) An additional Cu binding sequence found in the basic region in human and mouse PrPs immediately after the octarepeats. (3) PrPs from mammals and chicken show similar sequences, but human sequence was tested. (4) Well characterized analog for PrP helix 2 sequence was used [33]. The PrP helix 2 sequences varied among species but the Cu-anchoring H residue is highly conserved in various mammals such as mouse, bovine, ovine, tammar wallaby, brush-tailed possum, and Brazilian opossum.

Through in vitro studies with electron spin resonance spectroscopy, Allsop and his colleagues have shown that H₂O₂ (detected with a spin trap after conversion to HO^· via Fenton reaction) is produced during the early stages of protein aggregation associated with neurodegenerative diseases involving β-amyloid, α-synuclein and toxic forms of PrP [11-13]. Especially Cu-loaded PrP 106-126, the neurotoxic region, likely catalyzes the robust generation of H₂O₂ [12].

In addition to the Cu-loaded PrP peptide-dependent formation of H₂O₂, the present study reports the production of superoxide anion (O₂^•-), another key member of ROS in biological systems, by Cu-binding PrP fragments in the presence of certain co-factors. Previously, the author has proposed a hypothetical model mechanism in which Cu-bound form of PrP catalyzes the generation of ROS in the presence of some natural co-factors at specific occasions in the neuronal tissues [14]. The author has made a speculation that aromatic monoamines may form a group of such co-factors possibly contributing to the PrP-dependent oxidative burst [14] since Cu-bound PrP has high affinity and catalytic activity for oxidation of some aromatic monoamines such as dopamine which is abundantly present in neuronal tissues [15]. The aim of the present study is to test the hypothesis in which putative Cu-binding peptides derived from PrP function as possible catalysts for monoamine-dependent conversion of H₂O₂ to O₂^•- in vitro.

2. Materials and methods

Peptides

Four peptides corresponding to each Cu-binding sequence in PrP protein were synthesized to examine the behavior of such Cu-binding domains in chemiluminescence analysis of peptide-mediated oxidative burst. The peptides were obtained from the custom peptide service department of Sigma Genosis Japan (Ishikari, Hokkaido). The amino acid sequences of the peptides chemically synthesized and purified on high pressure liquid chromatography were (1) PHGGGWGQ (purity, 95.72%), (2) GGGTH (purity, 98.98%), (3) KTNMKHMA (purity, 98.85%) and (4) VNITKQHTVTTTT (purity, 99.02%).

Chemicals

2-Methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (Cypridina luciferin analog, CLA), a chemiluminescence reagent specific to O₂^•-, was purchased from Tokyo Kasei Kogyo Co. (Tokyo, Japan). Phenylethylamine (PEA), tyramine hydrochloride, and tryptamine hydrochloride were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Benzylamine, dopamine hydrochloride, and serotonin were from Nakalai Tesque Inc. (Kyoto, Japan). Other chemicals used in this study were of reagent grade purchased from Sigma (St. Louis, MO, USA).

Detection of superoxide

The peptides and other chemicals were dissolved in phosphate buffered saline and generation of O₂^•- was monitored by chemiluminescence of CLA with a CHEM-GLOW Photometer (American Instrument Co., MD., USA) equipped with a pen recorder, and expressed as relative luminescence units (rlu) as previously described [16]. CLA-chemiluminescence specifically indicates the generation of O₂^•- (and ¹O₂ with a lesser extent) but not that of O₃, H₂O₂ or HO^• [17]. According to our previous study, the signal for ¹O₂ can be minimized by avoiding the use of high concentration of organic solvents such as ethanol over 2% (v/v) in the culture media [18]. Thus the induced chemiluminescence recorded here reflects the generation of O₂^•- rather than ¹O₂.

3. Results

Aromatic monoamine-dependent oxidative burst catalyzed by the helical Cu-bound peptide

Since earlier studies suggested the high affinity of PrP towards dopamine and related monoamines [15], direct interactions between PrP-derived peptides and some aromatic monoamines leading to generation of O₂^•- was examined in phosphate buffered saline containing 5 µM CLA, by measuring the O₂^•--specific chemiluminescence. However, we observed no increase in O₂^•--dependent chemiluminescence in the reaction mixture simply consisted of peptides and aromatic monoamines (data not shown). Then, addition of other co-factors such as CuSO₄ and H₂O₂ were examined by analogy to the catecholamine-dependent oxidative burst-catalyzing enzymes such as copper-amine oxidases, monoamine oxidases and monoamine-oxidizing peroxidases. Here, generation of O₂^•- was examined by adding CLA, peptide, Cu, H₂O₂ and aromatic monoamines to phosphate buffered saline in this order. In the reaction mixture (200 µl) containing helical peptide (VNITKQHTVTTTT), Cu²⁺, H₂O₂, and phenylethylamine (PEA) with an approximate molar ratio of 1 : 3 : 3 : 10, a robust increase in the O₂^•--dependent chemiluminescence was observed (Fig. 2A). The observed burst of O₂^•- production was a biphasic event consisting of the acute spike and the gradual increase in O₂^•-. As discussed below, the PEA-induced acute spike can be observed in the Cu-H₂O₂ solution lacking peptides, only the later phase with gradual large increase in chemiluminescence must be attributed to the helical peptide-dependent reactions. Other peptides except for GGGTH also showed catalytic activity leading to biphasic O₂^•- production with lesser extents. Here again, only the secondary phase of oxidative burst must be considered as the consequences of peptide chemistry. Among the peptides, the activity of VNITKQHTVTTTT peptide sequence was outstanding thus is of great interests.

The cases of tyramine instead of PEA added to the reaction mixture containing 5 μM CLA, 0.3 µM helical peptide, 0.9 µM CuSO₄, and 1 mM H₂O₂ are shown in Fig. 2B. Effects of various aromatic amines namely PEA, tyramine, dopamine, serotonin, tryptamine, benzylamine, on generation of O₂^•- in peptide-Cu-H₂O₂ system were compared (Fig. 2B, upper inset). Among the aromatic monoamines, only three monoamines, PEA, tyramine, and benzylamine induced the generation of O₂^•-, and the structures of such active monoamines are shown in Fig. 2C. In addition, effects of two salicylates known to stimulate the conversion of H₂O₂ to O₂^•- by human methemoglobin [19,20] and various peroxidases [20], were also tested (Fig. 2B, upper inset). However, these salicylates were shown to be poor substrates for the generation of O₂^•- in this system. Interestingly, five related compounds inactive in induction of O₂^•- namely, serotonin, tryptamine, dopamine, salicylate and aspirin were shown to interfere with the PEA-induced O₂^•--generating reaction (Fig. 2B, lower inset), opening the ways for chemical and clinical modulation or manipulation of the monoamine-dependent oxidative burst in the PrP rich neuronal tissues.

As the helical peptide was shown to be most active among four Cu-binding peptides derived from PrP as the catalyst for PEA-dependent generation of O₂^•-, three other peptides less active towards PEA were shown to be also poorly active even towards tyramine and benzylamine (data not shown).

Among, three active monoamines, PEA is the most abundant species in neuronal tissues since PEA is a key precursor for many of catecholamine neurotransmitters. It is likely that reaction involving PEA is most likely to occur in the neuronal tissues compared to the reactions involving tyramine or benzylamine, thus following assays were carried out using PEA as a possible substrate.

Requirement for co-factors

In the reaction mixtures lacking either of 5 components namely CLA, helical peptide, Cu, H₂O₂ and aromatic monoamines, no drastic increase in the second phase of O₂^•--dependent chemiluminescence was observed, suggesting that any component is necessarily required for the reaction leading to generation and detection of O₂^•-. Typical results for peptide-Cu-H₂O₂-PEA system are shown (Fig. 3). Effects of the concentrations of helical peptide (Fig. 3A), copper (Fig. 3B), H₂O₂ (Fig. 3C), and PEA (Fig. 3D) on O₂^•- generation were examined. All components of the reaction were shown to act in concentration-dependent manners, further confirming that each component is necessary for the O₂^•- generating reaction and thus each component can be a limiting factor. Since the requirement for H₂O₂ was confirmed, the type of reaction catalyzed by the Cu-supplemented PrP helical sequence is rather similar to the aromatic monoamine oxidation reactions leading to O₂^•- generation catalyzed by H₂O₂-requiring plant peroxidases [21, 22] or human methemoglobin [19].

Here, the Cu-loaded peptide-dependent O₂^•- generation was shown to be fueled by H₂O₂ added to the reaction mixture. Actually, supply of H₂O₂ at the micro-domains on Cu-bound whole PrP is possible since Cu-loaded PrP 106-126, the neurotoxic region, is known to catalyze the production of H₂O₂ [12]. Despite of weak O₂^•--generating activity of KTNMKHMA corresponding to the neurotoxic sequence (Fig. 2A), this region may contribute to the oxidative burst by producing H₂O₂.

 Figure 2 

Superoxide-generating reactions catalyzed by the Cu-supplied PrP peptide fragments. (A) Typical traces of O₂^•--dependent chemiluminescence increase catalyzed by four putative Cu-binding PrP fragments are shown. Each reaction mixture contained CLA (5 μM), either peptide sequence as indicated (0.3 mM each), CuSO₄ (0.9 mM), H₂O₂ (1 mM) and PEA (3 mM). (B) Comparison of the actions of aromatic monoamines. Reaction mixtures contained 5 μM CLA, 0.3 mM helical peptide, 0.9 mM CuSO₄, 1 mM H₂O₂, and 3 mM of aromatic monoamies or salicylates. Typical traces for tyramine-induced oxidative burst with and without helical peptide are shown. The O₂^•--generating activities of related compounds were compared in upper inset. Asterisk, O₂^•- can be observed in serotonin-Cu solution lacking the peptide suggesting that observed chemilumienscence is not reflecting the peptide dependent generation of O₂^•-. The lower inset shows that five compounds shown to be inactive in oxidative burst induction, in turn inhibits the PEA-dependent O₂^•- generation. Prior to addition of PEA to the reaction mixture, each inhibitory compound (3 mM) was added. (C) Structures of aromatic monoamines active in Cu-loaded PrP helical peptide-dependent production of O₂^•-. (1) Phenylethylamine (PEA), (2) tyramine, (3) benzylamine.

 Figure 3 

Effects of the concentrations of peptide-, copper-, H₂O₂-, and PEA on superoxide generation. (A) Effect of the helical peptide concentration. (B) Effect of CuSO₄ concentration. (C) Effect of H₂O₂ concentration. (D) Effect of PEA concentration. Basically, the reaction mixtures contained constant amounts of CLA (5 μM), the helical peptide sequence (0.3 mM, exception in A), CuSO₄ (0.9 mM, exception in B), H₂O₂ (1 mM, exception in C) and PEA (3 mM, exception in D).

4. Discussion

Cu-binding sites on PrP

Importance of metalloproteins in neurobiology has been shown both as oxidant and antioxidant in neurodegenerative processes [4]. Cu is an essential trace element but its redox reactivity leads to the risk of damage to the cells and tissues, especially in neurodegenerative diseases such as Menkes' and Wilson's diseases occurring via disorders of Cu metabolism, and Alzheimer's disease and 'prion' diseases, the two major conformational diseases, as documented [23-25, etc]. The likely roles for Cu in induction of critical steps in the apoptotic pathways leading to neurodegeneration is outlined in the above reviews.

Recent studies have shown that PrPs can form a novel group of Cu-binding proteins [26,27]. Human PrP has four Cu-binding sites in the “octarepeats” region (PrP 60-91) in which amino acid sequence PHGGGWGQ appears four times and each repeat possibly binds single Cu²⁺ at physiological neutral and basic range of pH [28]. In general, the most relevant copper binding mode would involve formation of a 4:1 octarepeat:Cu complex involving coordination of one single Cu molecule by the 4 histidines on the 4 octarepeat segments of a single PrP molecule [29]. In chicken, the Cu-binding sites analogous to the octarepeats are known as hexa-repeats with each repeat consisting of the amino acid sequence HNPGYP and here again His residues play a key role in anchoring of Cu [30]. Morante et al. [31] showed that partial occupancy of Cu on bovine PrP is manifested by binding of Cu to PrP in the intermolecular or inter-octarepeat orientations while total occupancy of Cu is manifested by intra-repeat binding of Cu to the octarepeat region.

In vitro studies have shown that the actual least motif in the octarepeats necessarily required for binding of Cu consists of 4 amino acids HGGG [28] or 5 amino acids HGGGW [32]. Although there are additional Cu-binding sites on PrP such as amino acid regions 92-96 (GGGTH) [27], 124-126 (KHM) [10] and 180-193 (VNITIKQHTVTTTT) [33], and all studies suggested that His residue in each region (or each repeat unit) plays a key role in anchoring of Cu (Fig. 1). Based on above knowledge, four peptides corresponding to Cu-binding domains on PrP, namely PHGGGWGQ (repeated in PrP 60-91), GGGTH (PrP 92-96), KTNMKHMA (PrP 120-127) and VNITKQHTVTTTT (helical, PrP 180-193 analog) were synthesized in the present study and the helical Cu-binding motif was shown to be the most active in monoamine-dependent generation of O₂^•-. Although the octarepeat-dependent oxidative burst (second phase) was about one forth of the helical peptide-dependent one, this amino acid octet is repeated 4 times in human PrP and 6 times in bovine PrP, its contribution to oxidative burst in whole protein can be greater than that observed for the single repeat peptide.

Redox regulations

The amino-terminal part of PrP (23-98) is rich in amino acid residues susceptible to oxidation, such as His, Lys, Arg, and Pro, thus PrP is sensitive to oxidative changes such as production of ROS and the conformational changes in PrP may be readily induced by redox changes [15, 34]. In addition to the above amino acid residues on PrP, Met residues may be good targets for attacks by ROS. Recently, H₂O₂-dependent oxidation of Met residues has been reported for recombinant Syrian hamster PrP (29-231) [35]. The likely target residues include Met¹⁰⁹, Met¹¹², Met¹²⁹ and Met¹³⁴ and the susceptibility to oxidation of each Met residue was shown to be a function of accessibility to the solvent. While Cu-catalyzed oxidation leads to extensive aggregation of PrP, the H₂O₂-dependent Met oxidation on PrP leads only to a modest increase in β-sheet structure.

According to recently proposed model, there may be an intermediate structure of PrP between PrP^C and PrP^Sc, to be formed from PrP^C in response to cellular redox changes thus designated as PrP^RDX [36]. An in vitro study demonstrated that PrP^RDX of recombinant hamster PrP is catalytically active and capable of further conversion of PrP^C to PrP^RDX. At the end, PrP^RDX accumulates and disulfide bonds are formed among each PrP^RDX molecule, and lastly formation of PrP^Sc is completed. This attractive model successfully explained how pathogenic form of PrP could be propagated by the presence of an intermediate PrP.

Note that the PrP^RDX originally proposed by Lee and Eisenberg [36] was described to be in the oligomeric form distinct from the inert SH swapped dimeric form. Due to the nature of experimental design aimed to produce the redox-activated PrP oligomers at once from the SH-opened PrP monomers produced by exposing the bulk of PrP to the stepwise reduction and oxidation, their model (domain-swapping model) lacks the idea on the very initial event possibly occurring on a single molecule. Here the author wish to mention that PrP-catalyzed generation of O₂^•- (that may attack the SH residues on PrP) as a possible redox step(s) that converts the monomeric native PrP^C to the catalytically active monomeric PrP^RDX intermediate which in turn acts as the seed for further production of PrP^RDX from PrP^C, and to elongate the oligomers. The latest report by Shiraishi et al. [37] supports the view that the Cu bound to PrP undergoes catalytic cycling in the presence of catecholamines and causes the oxidation of protein, possibly involving the ROS-generating reactions which is sensitive to copper chelators, catalase and also to SOD, implying the involvements of H₂O₂ and O₂^•-. Possible contribution of PrP-catalyzed redox changes such as oxidation of catecholamines accompanying productions of H₂O₂ and O₂^•-, in aid of PrP^RDX generation is worth of further examination.

Abbreviations

CLA: Cypridina luciferin analog; HO^·: hydroxyl radicals; MAO: monoamine oxidase; O₂^•-: superoxide anion; PEA: phenylethylamine; PrP: prion protein; PrP^C: intrinsic cellular PrP; PrP^Sc: scrapie isoform of PrP; PrP^RDX: PrP redox intermediate; rlu: relative luminescence units; ROS: reactive oxygen species; SOD: superoxide dismutase; TSE: transmissible spongiform encephalopathies.

Conflict of interest

Declared none.

References

1. Jeffray M, McGovern G, Goodsir CM. et al. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol. 2000 ;191:323-32

2. Tabner BJ, Turnbull S, El-Agnaf O. et al. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem. 2001 ;1:507-17

3. Tabner BJ, El-Agnaf OMA, Turnbull S. et al. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia. J Biol Chem. 2005 ;280:35789-92

4. Opazo C, Barria MI, Ruiz FH. et al. Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. Biometals. 2003 ;16:91-8

5. Shiraishi N, Ohta Y, Nishikimi M. The octapeptide repeat region of prion protein binds Cu(II) in the redox inactive states. Biochem Biophys Res Commun. 2000 ;267:398-402

6. Wong BS, Brown DR, Pan T. et al. Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem. 2001 ;79:689-98

7. Sauer H, Dagdanova A, Hescheler J. et al. Redox-regulation of intrinsic prion expression in multicellular prostate tumor spheroids. Free Radic Biol Med. 1999 ;27:1276-83

8. Jones S, Batchelor M, Bhelt D. et al. Recombinant prion protein does not possess SOD-1 activity. Biochem J. 2005 ;392:309-12

9. Agostinho P, Oliveira CR. Involvement of calcineurin in the neurotoxic effects induced by amyloid-β and prion peptides. Eur J Neurosci. 2003 ;17:1189-96

10. Belosi B, Gaggelli E, Guerrini R. et al. Copper binding to the neurotoxic peptide PrP106-126: thermodynamic and structural studies. Chembiochem. 2004 ;5:349-59

11. Tabner BJ, Turnbull S, Fullwood NJ. et al. The production of hydrogen peroxide during early-stage protein aggregation: a common pathological mechanism in different neurodegenerative diseases?. Biochem Soc Trans. 2005 ;33:548-50

12. Turnbull S, Tabner BJ, Brown DR. et al. Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126. Neurosci Lett. 2003 ;336:159-62

13. Turnbull S, Tabner BJ, Brown DR. et al. Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP 121-231. Biochemistry. 2003 ;42:7675-81

14. Furuichi T, Kawano T. Possible application of electron spin resonance to monitoring of prion diseases and hypotheses on oxidative action and propagation of copper-bound infectious protein. Bull Nippon Sport Sci Univ. 2005 ;35:71-80

15. Shiraishi N, Nishikimi M. Carbonyl formation on a copper-bound prion protein fragment, PrP23-98, associated with its dopamine oxidase activity. FEBS Lett. 2002 ;511:118-22

16. Kawano T, Kawano N, Hosoya H. et al. Fungal auxin antagonist hypaphorine competitively inhibits indole-3-acetic acid-dependent superoxide generation by horseradish peroxidase. Biochem Biophys Res Commun. 2001 ;288:546-51

17. Nakano M, Sugioka K, Ushijima Y. et al. Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O₂-. Anal Biochem. 1986 ;159:363-9

18. Yokawa K, Suzuki N, Kawano T. Ethanol-enhanced singlet oxygen-dependent chemiluminescence interferes with the monitoring of biochemical superoxide generation with a chemiluminescence probe, Cypridina luciferin analog. ITE Lett Batter New Technol Medic. 2004 ;5:49-52

19. Kawano T, Pinontoan R, Hosoya H. et al. Monoamine-dependent production of reactive oxygen species catalyzed by pseudoperoxidase activity of human hemoglobin. Biosci Biotechnol Biochem. 2002 ;66:1224-32

20. Kawano T. Roles of the reactive oxygen species-generating peroxidase reactions in plant defense and growth induction. Plant Cell Rep. 2003 ;2:829-37

21. Kawano T, Pinontoan R, Uozumi N. et al. Aromatic monoamine-induced immediate oxidative burst leading to an increase in cytosolic Ca²⁺ concentration in tobacco suspension culture. Plant Cell Physiol. 2000 ;41:1251-8

22. Kawano T, Pinontoan R, Uozumi N. et al. Phenylethylamine-induced generation of reactive oxygen species and ascorbate free radicals in tobacco suspension culture: mechanism for oxidative burst mediating Ca²⁺ influx. Plant Cell Physiol. 2000 ;41:1259-66

23. Rossi L, Lombardo MF, Ciriolo MR. et al. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res. 2004 ;29:493-504

24. Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signaling at the synapse. J Neurochem. 2003 ;86:538-44

25. Rotilio G, Carri MT, Rossi L. et al. Copper-dependent oxidative stress and neurodegeneration. IUBMB Life. 2000 ;50:309-14

26. Aronoff-Spencer E, Burns CS, Avdievich NI. et al. Identification of the Cu²⁺ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 2000 ;39:13760-71

27. Burns CS, Aronoff-Spencer E, Legname G. et al. Copper coordination in the full-length, recombinant prion protein. Biochemistry. 2003 ;42:6794-803

28. Bonomo RP, Imperllizzeri G, Pappalardo G. et al. Copper II binding modes in the prion octapeptide PHGGWGGQ: a spectroscopic and voltammetric study. Chemistry. 2000 ;6:4195-202

29. Wells MA, Jelinska C, Hosszu LL. et al. Multiple forms of copper (II) coordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J 2006. [Epub ahead of print]

30. Stanczak P, Luczkowski M, Juszczyk P. et al. Interactions of Cu²⁺ ions with chicken prion tandem repeats. Dalton Trans. 2004 ;14:2102-7

31. Morante S, Gonzalez-Iglesias R, Potrich C. et al. Inter- and intra-octarepeat Cu(II) sites geometries in the prion protein. J Biol Chem. 2004 ;279:11753-9

32. Burns CS, Aronoff-Spencer E, Dunham CM. et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry. 2002 ;41:3991-4001

33. Brown DR, Guantieri V, Grasso G. et al. Copper(II) complexes of peptide fragments of the prion protein. Conformation changes induced by copper(II) and the binding motif in C-terminal protein region. J Inorg Biochem. 2004 ;98:133-43

34. Requena JR, Groth D, Legname G. et al. Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc Natl Acad Sci USA. 2001 ;98:7170-5

35. Requena JR, Dimitrova MN, Legname D. et al. Oxidation of methionine residues in the prion protein by hydrogen peroxide. Arch Biochem Biophys. 2004 ;432:188-95

36. Lee S, Eisenberg D. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat Struct Biol. 2003 ;10:725-30

37. Shiraishi N, Inai Y, Bi W. et al. Fragmentation and dimerization of copper-loaded prion protein by copper-catalysed oxidation. Biochem J. 2005 ;387:247-55

Author contact

Correspondence to: Prof. Tomonori Kawano Graduate School of Environmental Engineering, The University of Kitakyushu, Kitakyushu 808-0135, Japan. Tel: +81-93-695-3207, Fax: +81-93-695-3304. E-mail: kawanotomkitakyu-u.ac.jp

Received 2006-8-1
Accepted 2006-11-6
Published 2006-11-9

Citation styles

©2024 Ivyspring International Publisher. Terms of use